Skip to main content

Four years after the British coalition government of David Cameron unveiled efforts to fend off criticism that it was failing to provide expensive new cancer drugs, the strains in the system are again beginning to show.

In 2010, it created the Cancer Drugs Fund to pay for medicines rejected as not cost effective by the National Institute for Health and Care Excellence (Nice). Yet the fund not only undermined Nice’s authority; it has also run into difficulties after significantly overspending its budget of £200m a year.

By Andrew Jack, FT

To read the full article please visit this link and register with FT.com www.ft.com/cms/s/0/2e417874-1bcf-11e4-9db1-00144feabdc0.html#ixzz3EmY7LA9e

More News

Healing After War: WISH CEO to Open CVD Session at World Heart Summit
News
17 May 2025

Healing After War: WISH CEO to Open CVD Session at World Heart Summit

Read More
WISH Director Champions Action on Cardiovascular Disease at World Heart Summit 2025
News

WISH Director Champions Action on Cardiovascular Disease at World Heart Summit 2025

Read More
From Dialogue to Action: WISH Inspires Global Health Innovation at IUHPE 2025
News
13 May 2025

From Dialogue to Action: WISH Inspires Global Health Innovation at IUHPE 2025

Read More